In 2024, Sun Pharmaceutical Industries conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
In 2024, Sun Pharmaceutical Industries generated a total of 39,723 metric tonnes of waste.
Of this amount, 74.32% of Sun Pharmaceutical Industries's total waste generated was recovered through methods such as recycling, reuse, or composting, while 23.13% was disposed of through landfilling, incineration, or combustion. The remaining 2.55% was either treated using unspecified methods or not clearly categorized.
In 2024, Sun Pharmaceutical Industries reported a total waste generation of 39,723 metric tonnes, of which 74.32% was recovered through recycling, reuse, or composting. This moderate level of recovery indicates that Sun Pharmaceutical Industries is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.
Since 2024, Sun Pharmaceutical Industries's total waste generation has decreased by 8.11%, suggesting improvements in operational efficiency or the early results of waste minimization strategies.
Over the same period, Sun Pharmaceutical Industries's waste recovery rate increased by 2.51%.
In 2024, Sun Pharmaceutical Industries generated a total of 39,723 metric tonnes of waste.
Of this amount, 61.92% of Sun Pharmaceutical Industries's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 38.08% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.
Since 2024, Sun Pharmaceutical Industries's total waste generation has decreased by 8.11%, suggesting improvements in operational efficiency or the early results of waste minimization strategies.
Overall, Sun Pharmaceutical Industries's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.
In 2024, Sun Pharmaceutical Industries reported that 24,595 metric tonnes of its total waste output were classified as hazardous. This represents 61.92% of its overall waste generation.
The company treated this hazardous waste using a combination of methods. A majority (60.83%) was diverted from disposal through recovery-oriented treatments such as recycling or reuse. This suggests that Sun Pharmaceutical Industries has established processes to reduce the environmental burden of its most harmful waste streams.